Kyoto (iPS-AJ) Label License

1. SA Licensed Pluripotent Products

(i) End User shall not use SA Pluripotent Products and its derivatives for uses other than for End User’s internal use in the Field and in the Territory.

(ii) Notwithstanding above, if End User wishes to use SA Pluripotent Products and its derivatives in the Field for Commercial Purpose*, End User notifies AJ for such use, and End User will negotiate for a license to use SA Pluripotent Products and its derivatives with AJ and agree to take a required license.

(iii) End User shall not transfer, sell or supply any SA Pluripotent products and itsderivatives to third parties.

(iv) End User shall not use SA Pluripotent Products and its derivatives for application and use for human/animal therapeutic, diagnostic and/or prophylactic purposes including but not limited to clinical applications, cell therapy, transplantation, and/or regenerative medicine.

(v) No other right, express or implied, is conveyed by the sale of SA Pluripotent Products.

For avoidance of misunderstanding, any type of joint development between noncommercial organization and commercial organization in the field shall be considered as an internal use for “Commercial Purposes.”

2. Licensed Differentiated Cell

(i) End User shall not use Licensed Differentiated Cell for uses other than for End User’s internal use in the Field and in the Territory. For clarity, End User is allowed to use Licensed Differentiated cell in the Field for screening applications including but not limited to high-throughput screens inclusive of small molecules, antibodies, proteins, peptides, miRNA, etc. (i.e. large molecule screening.)

(ii) End user shall not transfer, sell or supply an Licensed Differentiated Cell to third parties.

(iii) End User shall not use Licensed Differentiated Cell for application and use for human/animal therapeutic, diagnostic and/or prophylactic purposes including but not limited to clinical applications, cell therapy, transplantation, and/or regenerative medicine.

(iv) No other right, express or implied, is conveyed by the sale of Licensed Differentiated Cell.